Tech Company Financing Transactions
Mycell Technologies Funding Round
Mycell Technologies, based in Montvale, secured $356.9 thousand from private investors.
Transaction Overview
Company Name
Announced On
2/16/2016
Transaction Type
Debt
Amount
$356,945
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 4 investors participated in the offering as amended. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
160 Summit Ave. 101
Montvale, NJ 07645
USA
Montvale, NJ 07645
USA
Phone
Website
Email Address
Overview
Mycell Technologies is an ingredients and technology company that develops proprietary liquid formulation of stable, highly concentrated Omega-3s for use in food, beverage, medical and nutritional products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin Mamola
Chief Operating Officer
Joseph Krasinski
Chief Scientific Officer
Bruce Lipshutz
Chief Technical Officer
Volker Berl
VP - Marketing
Stephanie Perine
VP - Operations
Gregory Paddon-Jones
Browse more venture capital transactions:
Prev: 2/16/2016: LiveAction venture capital transaction
Next: 2/17/2016: Kontakt.io venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs